Michael Pichichero

Michael E. Pichichero is Director, Rochester General Hospital Research Institute; Research Professor, Rochester Institute of Technology; and a clinical professor in the Department of Pediatrics at the University of Rochester Medical Center.[1] He is the author of a number of scientific studies regarding the safety of thimerosal as a preservative in vaccines.

Michael E. Pichichero
Alma materUniversity of Rochester School of Medicine
Known forThimerosal controversy
AwardsBreese Award for Outstanding Contribution to Clinical Research, Teaching and Practice, 2005
Scientific career
FieldsPediatrics, toxicology
InstitutionsUniversity of Rochester Medical Center, Rochester General Hospital Research Institute

Biography

Pichichero received his undergraduate degree from Rutgers University, and his medical degree from the University of Rochester.[2] He did post graduate training at the University of Colorado, Denver. He completed fellowships in Pediatric Infectious Diseases and Adult and Pediatric Allergy and Immunology at the University of Rochester, NY

Scientific career

Pichichero's studies say that ethylmercury, the metabolite of thimerosal, is rapidly metabolized and excreted after administration of thimerosal-containing vaccines, as well as that administration thereof does not raise blood mercury levels above the EPA's lower limit. In addition, his research has concluded that ethylmercury is metabolized about six times as fast as methylmercury (the kind of mercury found in fish), and that the former has a blood half-life of about 3.7 days whereas the latter has a half-life of 44 days.[3] His research says that after children receive a vaccine with thimerosal in it, their blood mercury levels return to normal within only a month.[4][5]

Pichichero has written a textbook about streptococcal pharyngitis.[6] A board-certified immunologist, he was on the team of scientists at the University of Rochester who invented the Hib vaccine.[7] His more recent research, however, has focused on ear infections and their treatment with antibiotics.[8]

==Selected publications Michael E. Pichichero, Elsa Cernichiari, Joseph Loprieto, John Treanor. Mercury concentrations and metabolism in infants: a descriptive study. Lancet 2002; 360: 1737'41.

Michael Pichichero, Angela Gentile, N Giulio, V Umido, T Clarkson, E Cernichiari, G Zareba, C Gotelli, M Gotelli, L Yan, J Treanor. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Pediatrics 2008; 121: e208-214.

Porter Anderson, Michael Pichichero. Richard Intel. Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenza type b coupled to diphtheria toroidal or the toxin protein CRM 197. J Clinical Investigation 1985; 76: 52-59.

Porter Anderson, John Treanor, Sue Porcelli. Michael Pichichero. Non-interference between two protein carriers when used with the same polysaccharide for pneumococcal conjugate vaccines in two year old children. Vaccine 2003; 21: 1554-59.

Michael Pichichero. Booster vaccinations: Can immunologic memory outpace pathogenesis? Pediatrics 2009; 124: 1633-41.

Michael Pichichero, J Casey, A Almudevar, S Basha, N Sarandon, R Kaur, M Morris, A Livingstone, T Mosmann. Functional immune cell differences associated with low vaccine responses in infants. J Inf Dis 2016; 213: 2014-19.

Michael Pichichero. Ten year study of acute otitis media. Pediatric Inf Dis J 2016; 35: 1027-32.

Michael Pichichero. Immunologic dysfunction contributes to the otitis prone condition. J Infection 2020; 80: 614-22.

References
  1. "Michael E. Pichichero". University of Rochester Medical Center. Retrieved 31 August 2013.
  3. Barclay, Laurie (3 December 2002). "Mercury in Vaccines: A Newsmaker Interview With Michael E. Pichichero, MD". Medscape. Retrieved 31 August 2013.
  4. Johnson, Carla K. (31 January 2008). "Study: Mercury fades quickly from blood". USA Today. Retrieved 31 August 2013.
  5. Reinberg, Steven (23 March 2008). "Mercury in Childhood Vaccines Excreted Quickly". ABC News. Retrieved 5 November 2013.
  6. Pichichero, Michael (2007). Clinical Management of Streptococcal Pharyngitis. Professional Communications.
  7. "Our Researchers". Rochester General Health System. Retrieved 31 August 2013.
  8. Dooren, Jennifer (17 October 2007). "Ear Bacteria Resist Treatment". Wall Street Journal. Retrieved 25 November 2014.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.